PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.\', \'Department of General Internal Medicine, Ghent University Hospital, Ghent, Belgium.\', \'Department of Neurology, Ghent University Hospital, Ghent, Belgium.\', \'Department of Neurology, Algemeen Ziekenhuis (AZ) Sint-Jan Brugge Oostende, Bruges, Belgium.\', \'Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium.\', \'Primary Immunodeficiency Research Lab, Ghent University, Ghent, Belgium.\', \'Department of Haematology, Ghent University Hospital, Ghent, Belgium.\', \'Department of Nephrology, Ghent University Hospital, Ghent, Belgium.\', \'Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/fimmu.2022.858399
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 35401575
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all